Journal article
Atypical hypersensitivity reaction to botulinum toxin injection: a case report
Revista Headache Medicine (Online), v 14(2), pp 108-111
18 Sep 2023
Abstract
Botulinum toxin type A (BTA) injection, marketed as BOTOX, is commonly used as a treatment for a variety of clinical indications and is widely viewed as safe, effective and largely devoid of serious side effects. Anaphylactic reactions to BTA are typically unheard of in the scientific literature. BOTOX is approved by the Food and Drug Administration for the treatment of cervical dystonia and prophylaxis for chronic migraines. This case report documents a unique instance of allergic reaction to BTA in a 29-year-old woman with cervicogenic headache and cervical dystonia who reported immediate flushing, light-headedness and nausea after receiving BTA injections.
Metrics
1 Record Views
Details
- Title
- Atypical hypersensitivity reaction to botulinum toxin injection: a case report
- Creators
- Joe H. Ghorayeb - University of Medicine and Health SciencesTimithy McClellan - Drexel UniversityKelley Crozier - Drexel University
- Publication Details
- Revista Headache Medicine (Online), v 14(2), pp 108-111
- Publisher
- Brazilian Headache Society
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- General Internal Medicine
- Scopus ID
- 2-s2.0-105040223436
- Other Identifier
- 991022193497404721